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Abstract
Escherichia coli represents a classical intestinal gram-negative commensal. Despite this
commensalism, different E. coli strains can mediate disparate immunogenic properties in a
given host. Symbiotic E. coli strains such as E. coli Nissle 1917 (EcN) are attributed benefi-
cial properties, e.g., promotion of intestinal homeostasis. Therefore, we aimed to identify
molecular features derived from symbiotic bacteria that might help to develop innovative
therapeutic alternatives for the treatment of intestinal immune disorders. This study was per-
formed using the dextran sodium sulphate (DSS)-induced colitis mouse model, which is rou-
tinely used to evaluate potential therapeutics for the treatment of Inflammatory Bowel
Diseases (IBDs). We focused on the analysis of flagellin structures of different E. coli
strains. EcN flagellin was found to harbor a substantially longer hypervariable region (HVR)
compared to other commensal E. coli strains, and this longer HVR mediated symbiotic prop-
erties through stronger activation of Toll-like receptor (TLR)5, thereby resulting in interleukin
(IL)-22–mediated protection of mice against DSS-induced colitis. Furthermore, using bone-
marrow–chimeric mice (BMCM), CD11c+ cells of the colonic lamina propria (LP) were iden-
tified as the main mediators of these flagellin-induced symbiotic effects. We propose flagel-
lin from symbiotic E. coli strains as a potential therapeutic to restore intestinal immune
homeostasis, e.g., for the treatment of IBD patients.
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Introduction
E. coli belongs to the phylum of gram-negative Proteobacteria. Besides certain pathogenic
strains, E. coli represents a commensal member of the intestinal microbiota. However, distinct
commensal E. coli strains can mediate substantially different immunological host responses.
On the one hand, so-called “pathobionts” may induce severe pathological inflammatory reac-
tions in a certain genetically predisposed or environmentally challenged host. On the other
hand, “symbionts” generally provide beneficial effects and do not induce inflammatory
responses at intestinal mucosal interfaces [1]. Although Escherichia is usually not among the
most abundant bacterial genera within a healthy, balanced, and diversified intestinal micro-
biota [2,3], the impact of enhanced proportions of Proteobacteria in general and E. coli strains
in particular on inflammatory processes in Inflammatory Bowel Disease (IBD) patients has
widely been reported [4–7]. This observation leads to questions concerning mechanistic and
structural differences between symbiotic and nonsymbiotic commensal E. coli strains and
their subsequent impact on IBD pathology. One of the most intensely studied symbiotic E. coli
strains is E. coli Nissle 1917 (EcN). EcN is generally classified as a probiotic and is the only bac-
terial symbiont that is successfully used to extend remission phases in IBD patients in clinical
routine [8]. In this context, EcN mediates similar therapeutic effects as mesalamine, the gold
standard therapeutic to extend remission time in ulcerative colitis (UC) patients [9–11]. EcN
provides different beneficial properties such as (1) the formation of biofilms [12] leading to the
production of defensins [12,13], (2) strengthening of tight junctions within the intestinal epi-
thelium [14], (3) direct antimicrobial effects via secretion of bacteriocins and microcins [15],
and (4) direct interaction with the host immune system [16].
However, most of these effects are thought to require viable EcN bacteria, and the recom-
mended therapeutic EcN dose comprises extremely high numbers of vital cells [2]. In general,
administration of viable bacteria involves the risk of proactive bacterial translocation across
the epithelial barrier, particularly in inflamed intestinal tissue, which provides a disturbed bar-
rier integrity. Thus, use of live bacteria for the treatment of ongoing inflammatory reactions
bears considerable risks. Therefore, it appears desirable to identify bacterial factors that distin-
guish symbiotic from nonsymbiotic E. coli strains. Such identified symbiotic factors could
then be used as novel therapeutic approaches to restore gut immune homeostasis and could
offer a wide range of potential clinical applications.
The investigation of commensal bacteria-mediated symbiotic properties requires the use of
adequate mouse models. One of these mouse models involves the application of dextran
sodium sulphate (DSS). Administration of DSS leads to an IBD-resembling phenotype in mice
of almost all genetic backgrounds [17]. The similarities between IBD in humans and DSS-
induced colitis in mice include a similar inflammatory gene expression pattern [18], T-cell
accumulation in the colon [19], and the development of a chronic pathology after initial acute
inflammation involving a T helper (Th)1/Th2 cytokine secretion pattern [20]. As in IBD
patients, DSS-induced colitis in mice leads to influx and transepithelial migration of neutro-
phils into the mucosal epithelium and lumen, leading to the formation of crypt abscesses [21–
24]. Furthermore, DSS-induced colitis in mice provides comparable sensitivity toward thera-
peutics as in IBD [25], making this model appropriate for preclinical studies involving the eval-
uation of new potential treatments for IBD patients [26], e.g., commensal-derived molecular
features such as surface-associated structures.
Various bacterial surface structures serve as so-called microbe-associated molecular pat-
terns (MAMPs), molecules that are recognized by host pattern-recognition receptors (PRRs),
e.g., Toll-like receptors (TLRs) [27]. PRR sensing leads to activation of the innate and modula-
tion of the adaptive immune system. One of these MAMPs is flagellin, the constitutive protein
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building up bacterial flagella. Flagellin typically consists of different structural domains: all fla-
gellins contain N-terminal and C-terminal D0 and D1 domains that form the structurally
highly homogenous so-called “conserved region” [28–30]. Some flagellins, such as most E. coli
flagellins, additionally contain a “hypervariable region” (HVR) made up of C- and N-terminal
D2 domains as well as of a central D3 domain [28]. Extracellular flagellin is recognized only as
a monomer [29] by host TLR5 [30], leading to myeloid differentiation primary response
(MyD)88-dependent activation of nuclear factor “kappa-light-chain–enhancer” of activated B-
cells (NFκB) [31,32]. Interestingly, flagellin represents a major target antigen in human IBD
patients as well as in experimental mouse models for colitis [33]. Additionally, certain TLR5
SNPs are associated with higher incidence of UC [34] and colon cancer [35]. Furthermore,
TLR5-deficient mice are prone to develop spontaneous intestinal inflammation [36], and
intestinal TLR5 signaling was demonstrated to be crucial for preventing gut inflammation and
metabolic syndrome in mice [37].
Taking these data together, flagellin recognition by intestinal TLR5-expressing host cells
seems to be crucially involved in shaping host immunity, leading to maintenance of intestinal
immune homeostasis. Therefore, we hypothesized that the precise flagellin structure could be
a decisive factor that allows for a distinction between symbiotic and nonsymbiotic E. coli
strains. Here, we demonstrate that EcN flagellin is sufficient to mediate a crucial part of EcN’s
symbiotic properties via TLR5 on intestinal CD11c+ cells within the lamina propria (LP). Fur-
thermore, we provide evidence that the structure of the flagellin HVR is a decisive factor that
classifies EcN as a symbiont. In consequence, symbiotic HVR containing flagellin structures
might be used as innovative therapeutic approaches for the treatment of IBD.
Results
Interaction of EcN flagella with host TLR5 is crucial for the beneficial
effects of EcN during DSS-induced colitis
EcN is the only symbiont with verified symbiotic effects on the outcome and progression of
UC in humans [8] as well as in DSS-induced colitis in mice [38–40]. For these reasons, we
decided to use the DSS-induced colitis model for the elucidation of E. coli-mediated effects on
colitis pathology. Administration of 3.5% DSS in the drinking water led to strong loss of body
weight in wild-type (WT) C57BL/6 mice (Fig 1A), accompanied by severe tissue changes and
leukocyte influx, as indicated by high histological colitis scores (HCSs) (Fig 1B). In agreement
with previous studies [38–40], administration of viable symbiotic EcN provided beneficial
effects on the outcome of DSS-induced colitis in WT BL/6 mice, characterized by drastically
reduced weight loss and HCS (Fig 1A and 1B). Therefore, we were interested in how other
commensal E. coli strains influence the progress and outcome of DSS-induced colitis and
which structural features of these strains might mediate potentially observed differences.
Therefore, we administered two additional E. coli strains in the same concentration as EcN,
which resulted in comparable E. coli colony-forming units (CFUs) in the feces of all groups (S1
Fig), and monitored disease progression and outcome compared to DSS-only–treated WT
mice; specifically, the well-known commensal strains (1) E. coli K12 MG1655 (MG1655) and
(2) E. coli mpk (MPK) [41–44] were used. Importantly, these strains do not mediate symbiotic
properties in various mouse models for microbiota-influenced pathologies [41,43,45], and in
contrast to treatment with EcN, administration of MPK and MG1655 did not provide any ben-
eficial effects on the outcome of DSS-induced colitis since the HCS of both groups was compa-
rable to the DSS-only control group (Fig 1B), and weight loss was only slightly reduced.
Given the direct effect of flagellin on TLR5-signaling and its impact on intestinal immune
homeostasis [36,37], we hypothesized that the protective effect of EcN was at least partially
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Fig 1. Influence of different commensal E. coli strains on DSS-induced colitis in WT and Tlr5−/− mice. (a + b) SPF C57BL/6 WT mice aged 6 to 8
weeks were administered 3.5% DSS in drinking water at day 0. Mice were additionally treated with EcN (DSS + EcN), MG1655 (DSS + MG1655), or
MPK (DSS + MPK) resuspended in DSS-containing drinking water at 108 bacteria mL−1. (a) Change in body weight relative to start of DSS
administration at day 0. (b) Left panel: HE-stained colonic sections at day 7 after start of DSS administration. Right panel: HCS at day 7. (c + d) SPF
C57BL/6 WT mice aged 6 to 8 weeks were administered 3.5% DSS in drinking water at day 0. Mice were additionally treated with EcN (DSS + EcN)
or an EcNΔfliC deletion mutant (DSS + EcNΔfliC) resuspended in DSS-containing drinking water at 108 bacteria mL−1. (c) Change in body weight
relative to start of DSS administration at day 0. (d) Left panel: HE-stained colonic sections at day 7 after start of DSS administration. Right panel: HCS
at day 7. (e) SPF C57BL/6 WT mice and SPF Tlr5−/− mice aged 6 to 8 weeks were administered 3.5% DSS in drinking water at day 0. Mice were
additionally treated with EcN (DSS + EcN) or an EcNΔfliC deletion mutant (DSS + EcNΔfliC) resuspended in DSS-containing drinking water at 108
bacteria mL−1. Left panel: HE-stained colonic sections at day 7 after start of DSS administration. Right panel: HCS at day 7. Statistics: (a), (b), (c), (e),
one-way ANOVA with Tukey multiple comparison test; (d) Kruskal–Wallis test with multiple comparisons. p-values< 0.05 are considered to
represent statistical significance. (a–e) The data underlying this figure can be found in S1 Data. DSS, dextran sodium sulphate; EcN, E. coli Nissle
1917; fliC, flagellin; HCS, histological colitis score; HE, hematoxylin–eosin; MG1655, E. coli K12 MG1655; MPK, E. coli mpk; SPF, specific-pathogen–
free; TLR, Toll-like receptor; WT, wild type.
https://doi.org/10.1371/journal.pbio.3000334.g001
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mediated by its flagella. In order to test this hypothesis, an EcN mutant lacking the fliC gene
encoding for flagellin (EcNΔfliC) [46] was administered to DSS-treated mice. While EcN,
MG1655, and MPK each harbor a functional flagellum (S2 Fig), EcNΔfliC does not (S3 Fig).
Fecal E. coli CFUs in all bacteria-treated groups were comparable (S1A Fig). Whereas weight
loss was only partially rescued by administration of live EcNΔfliC in the drinking water (Fig
1C), absence of flagellin in this strain completely abrogated the positive effect on histological
damage observed for flagellin-expressing EcN and was comparable to DSS-only–treated con-
trol mice, providing strong signs of intestinal inflammation (Fig 1D). This indicated that the
presence of flagella is crucial for mediation of protective properties of EcN in this mouse
model. Since the flagellum and its constituent protein flagellin are recognized by host TLR5,
we performed DSS-induced colitis experiments using TLR5-deficient (Tlr5−/−) mice.
Dependent on the housing conditions, Tlr5−/− mice either spontaneously develop a chronic
form of colitis and/or metabolic syndrome [37,47,48] or not [49]. Our specific-pathogen–free
(SPF) housing conditions did not lead to spontaneous intestinal disorders and did not differ-
ently affect the outcome of DSS-induced colitis in Tlr5−/− mice compared to their equally
treated WT counterparts (Fig 1E), though Tlr5−/− mice treated with EcN showed significantly
increased histological damage compared to EcN-treated WT mice, resembling the disease phe-
notype that was observed in DSS-only–treated WT and Tlr5−/− mice (Fig 1E). Administration
of EcNΔfliC to DSS-treated Tlr5−/− mice did not positively affect the outcome of experimental
colitis, as demonstrated by HCSs comparable to EcNΔfliC-treated WT mice and to DSS-only–
treated mice of both genotypes (Fig 1E; see also S1 Table for detailed statistical analysis).
Importantly, fecal E. coli CFUs in all bacteria-treated groups in Tlr5−/− mice were comparable
(S1B Fig). Therefore, we concluded that the beneficial effects of symbiotic EcN on the progress
and outcome of DSS-induced colitis is mainly mediated by the interaction of host TLR5 with
EcN flagella.
Flagella-mediated inflammation-suppressing effects are specific for EcN
flagella-enriched preparations and are not mediated by preparations from
other commensal E. coli strains
Since all three E. coli strains used—EcN, MPK, and MG1655—expressed a functional flagel-
lum, we hypothesized that the different effects on DSS-induced colitis mediated by distinct E.
coli strains were not caused by the presence of a flagellum per se but rather were rooted in
structural differences in their flagellin protein structures. To test this and to exclude the contri-
bution of factors requiring viable bacteria, we generated flagella-enriched preparations (FEPs)
from symbiotic EcN and nonsymbiotic MG1655 and MPK as described in the experimental
procedures, and these FEPs were devoid of any viable bacteria. Fig 2A demonstrates that the
EcN FEP recapitulated the protective effects on the outcome of DSS-induced colitis in WT
mice observed for viable EcN. This effect was dose dependent, with the FEP obtained from
1010 EcN per mL drinking water providing the strongest inflammation-reducing effects, as
indicated by absent weight loss (Fig 2A) and low HCS of DSS-treated animals (Fig 2B).
According to the results shown in Fig 2A and 2B, we performed all further experiments by
default with the FEP obtained from 1010 bacteria per mL drinking water, which was thought to
induce a strong TLR5-mediating signaling. Next, we compared the FEP from EcN with the
FEPs obtained from MPK (MPK FEP) and MG1655 (MG1655 FEP). We verified that FEPs
generated from each of the tested strains contained similar concentrations of endotoxin, over-
all protein, and flagellin (S4A–S4E Fig). Thus, DSS-treated WT mice were administered MPK
FEP as well as MG1655 FEP and compared to DSS-treated WT mice, which were administered
EcN FEP. As demonstrated in Fig 2C and 2D, neither MPK FEP nor MG1655 FEP provided
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Fig 2. Flagella-dependent influence of different commensal E. coli strains on DSS-induced colitis in WT mice. (a + b) SPF C57BL/6 WT mice aged
6 to 8 weeks were administered 3.5% DSS in drinking water at day 0. Mice were additionally treated with FEPs obtained from 107 (EcN FEP 107) and
1010 (EcN FEP 1010) EcN per 100 mL drinking water. (a) Change in body weight relative to start of DSS administration at day 0. (b) Left panel: HE-
stained colonic sections at day 7 after start of DSS administration. Right panel: HCS at day 7. (c + d) SPF C57BL/6 WT mice aged 6 to 8 weeks were
administered 3.5% DSS in drinking water at day 0. Mice were additionally treated with FEPs obtained from 1010 EcN, MG1655, or MPK per 100 mL
drinking water. (c) Change in body weight relative to start of DSS administration at day 0. (d) Left panel: HE-stained colonic sections at day 7 after start
of DSS administration. Right panel: HCS at day 7. (e) mTLR5-HEK293 cells were stimulated with FEP obtained from EcN, MG1655, and MPK for 24 h.
FEPs were generated from the number of bacteria corresponding to a certain MOI (quasi-MOI). Resulting IL-8 secretion into cell supernatant as a
result of TLR5 receptor activation was detected by ELISA. (f) mTLR5-HEK293 cells were stimulated with EcN and EcNΔfliC at different MOI for 24 h.
Resulting IL-8 secretion into cell supernatant as a result of TLR5 receptor activation was detected by ELISA. (g + h) SPF C57BL/6 WT mice aged 6 to 8
weeks were administered 3.5% DSS in drinking water at day 0. Mice were additionally treated with 1010 viable bacteria of the indicated
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any beneficial effects concerning DSS-induced colitis in WT mice, indicating that the molecu-
lar nature of flagellin impacted on this process.
To assess whether this was reflected at the level of TLR5 activation, we used human embry-
onic kidney cells overexpressing mouse TLR5 (mTLR5-HEK293), stimulated them with either
viable bacteria or FEPs, and measured the resulting interleukin (IL)-8 secretion to quantify
TLR5-dependent NFκB activation. When comparing EcN FEP, MG1655 FEP, and MPK FEP,
the latter FEPs from nonsymbiotic bacteria completely failed to activate the mouse TLR5
receptor in any tested concentration, while EcN FEP provided a concentration-dependent sig-
naling intensity, as demonstrated by differential NFκB-activation–dependent IL-8 secretion
from mTLR5-HEK293 cells (Fig 2E). Of note, a strong effect on NFκB activation was also
observed for viable EcN but not EcNΔfliC (Fig 2F). Thus, we assumed that flagellin of symbi-
otic EcN might feature a distinct property that is absent in nonsymbiotic E. coli strains. To
explore this in detail, different complementation mutants were generated: (1) an MG1655ΔfliC
mutant was complemented with the fliC gene from EcN (MG1655ΔfliC::fliC(EcN)), and (2) an
EcNΔfliC mutant was complemented with the fliC gene from MPK (EcNΔfliC::fliC(MPK))
(see S5 Fig for details on complementation). Both mutants provided efficient flagella expres-
sion and adequate mobility as demonstrated by electron microscopy and bacterial swarming
assays (S6 Fig), indicating that the exchange mutation did not negatively affect flagellum
expression and function. Both complemented viable strains were administered to DSS-treated
mice, and the disease outcome was monitored as before (Fig 2G and 2H). Although a slight
reduction in body weight was observed in DSS-treated animals that were administered
MG1655ΔfliC::fliC(EcN) (Fig 2G), the damage of colonic tissue was significantly lower com-
pared to DSS-treated mice without additional bacterial administration (Fig 2H). However,
administration of EcNΔfliC::fliC(MPK) did not provide any beneficial effects on DSS-induced
colitis, as indicated by strong weight loss and increased HCS (Fig 2G and 2H). Therefore, we
concluded that the inflammation-reducing features of the EcN flagella are specific for this
strain and are not present in the flagella of MG1655 or MPK. However, this raises the question
of which structural features might account for the differences of the EcN FliC protein com-
pared to FliC from nonsymbiotic E. coli strains.
Insertions within the HVR of flagellin account for the symbiotic effects of
EcN compared to nonsymbiotic E. coli strains
FliC proteins consist of a constant region comprising one N- and one C-terminal D0 and D1
domain (NTD0, NTD1, CTD0, and CTD1). Some bacteria—e.g., Escherichia and Salmonella
strains—additionally contain an HVR composed of a C- and N-terminal D2 (NTD2, CTD2)
domain as well as a central D3 domain (Fig 3A). As expected, sequence alignment compari-
sons between FliC of EcN, MG1655, and MPK revealed that in the constant region, the
sequence similarity of the 4 domains exceeds 95% (Fig 3B and 3C). This constant region is
thought to be the primary mediator of TLR5 activation [30,28], However, sequence similarity
of the N- and C-terminal D2 domains within the HVR is 65% (NTD2) and 64% (CTD2)
between EcN FliC and MG1655 FliC, as well as 61% (NTD2) and 64% (CTD2) in the case of
complementation mutants per 100 mL DSS-containing drinking water. (g) Change in body weight relative to start of DSS administration at day 0. (h)
Left panel: HE-stained colonic sections at day 7 after start of DSS administration. Right panel: HCS at day 7. Statistics: (a), (c), (g), one-way ANOVA
with Tukey multiple comparison test; (b), (d), (h), Kruskal–Wallis test with multiple comparisons. p-values< 0.05 are considered to represent statistical
significance. The data underlying this figure can be found in S1 Data. DSS, dextran sodium sulphate; EcN, E. coli Nissle 1917; FEP, flagella-enriched
preparation; fliC, flagellin; HCS, histological colitis score; HE, hematoxylin–eosin;; IL, interleukin; MG1655, E. coli K12 MG1655; MOI, multiplicity of
infection; MPK, E. coli mpk; mTLR5-HEK293 cell, mouse-TLR5–expressing human embryonic kidney 293 cell; SPF, specific-pathogen–free; TLR, Toll-
like receptor; WT, wild type.
https://doi.org/10.1371/journal.pbio.3000334.g002
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Fig 3. Detailed comparison of the flagellin amino-acid sequences of different E. coli strains. Protein alignment of FliC proteins from EcN
(CCQ05465.1), MPK, and MG1655 (NP_416433.1) genomes. (a) Schematic structure of flagellin according to Yonekura and colleagues [50,51]. D0
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comparing EcN FliC with MPK FliC. The differences between D3 domain sequences is even
lower than 50% sequence similarity for both comparisons (Fig 3B and 3C). These low numbers
in relative sequence similarity are mainly due to the presence of numerous sets of amino-acid
inserts within the HVR of EcN flagellin compared to the corresponding regions of MG1655
flagellin and MPK flagellin (Fig 3D), thus rendering the NTD2, D3, and CTD3 domains of
EcN substantially longer. However, not only the length but also the amino-acid sequence of
the HVR is highly different, both in comparison between EcN and MG1655 or EcN and MPK
and also between MG1655 and MPK.
Deletions within the HVR of FliC leads to loss of EcN inflammation-
reducing properties
In order to check whether the different HVR structure is causative for the observed disparities
in influencing the progress of DSS-induced colitis, we deleted large parts of the EcN fliC HVR,
namely a short part of the NTD2 domain as well as large parts of D3 and the entire CTD2
domain (EcNΔfliC(HVR)) (Fig 4A). This deletion resulted in a significantly shorter assembled
flagellum compared to WT EcN, providing only about 10% of the length of WT EcN flagella
(S7 Fig). We administered EcNΔfliC(HVR) as a viable bacterium to DSS-treated mice and
checked for changes in body weight, followed by histological analysis of the colonic tissue 7
days after the start of DSS treatment. As demonstrated in Fig 4B and 4C, there were no detect-
able inflammation-preventing effects when the EcNΔfliC(HVR) deletion mutant was used, as
indicated by strong weight loss (Fig 4B) and high HCSs (Fig 4C), which was in sharp contrast
to WT EcN (Fig 1A–1D). In conclusion, these experiments show that insertions within the fla-
gellin HVR are responsible for the disease-ameliorating properties of EcN flagellin. To gain
insight into the effect of HVR modulation on systemic inflammation, we determined serum
concentrations of 13 pro- and anti-inflammatory cytokines in DSS + EcN-treated, DSS
+ EcNΔfliC(HVR)-treated, and DSS-only–treated mice to characterize the influence of the fla-
gellin HVR on the cytokine-associated protective properties of EcN in this mouse model. Con-
sistent with reports showing that DSS-treated mice provide increased serum levels of, e.g.,
tumor necrosis factor (TNF)α, IL-6, IL-1β, and IL-17 compared to healthy non-DSS–treated
controls [52,53], colonic inflammation led to a systemic increase of proinflammatory cyto-
kines, which translated into elevated serum concentrations. Fig 4E depicts a heat map of all
detected cytokines in each mouse of the three respective groups. We detected significantly
higher serum levels of the proinflammatory cytokines IL-1β, IL-1α, TNFα, IL-6, and IL-17A as
well as of the anti-inflammatory cytokines IL-27, IL-10, and interferon (IFN)β in DSS-only–
and DSS + EcNΔfliC(HVR)-treated mice compared to DSS + EcN-treated mice (Fig 4E, see
also S1 Table for detailed statistical analysis). Therefore, we concluded that the presence
of the full HVR is a precondition for the EcN-mediated symbiotic effects during DSS-
induced colitis in WT mice, and its deletion results in loss of protection against intestinal
inflammation.
and D1 comprise conserved N- and C-termini of fliC, packed into α-helical structures in the filament core. The NTD2/CTD2- and D3-domain–
containing HVR is attached adjacent to the D2 domains, located at the outer surface of the filament. (b) Quantification of amino-acid sequence
similarities of all 6 flagellin domains. Computation was performed using similarity indices depicted in 3c. (c) The alignment was generated using
MAFFT. Amino acids were colored by overall conservation (white: fully conserved, light blue to dark blue: high to low conservation). Consensus
sequence and sequence conservation for pairwise comparisons of EcN to MPK and MG1655, respectively, are shown in yellow. Darker shades of
yellow represent lower sequence conservation. (d) Schematic overview of the differences of the EcN flagellin HVR compared to the HVRs of both
MG1655 and MPK. Sequences (insertions) that are only present in EcN HVR and not in MPK HVR or MG1655 HVR are highlighted as colored
squares. AA, amino acid; CTD, C-terminal domain; EcN, E. coli Nissle 1917; fliC, flagellin; HVR, hypervariable region; MAFFT, Multiple
Alignment using Fast Fourier Transform; MG1655, E. coli K12 MG1655; MPK, E. coli mpk; NTD, N-terminal domain.
https://doi.org/10.1371/journal.pbio.3000334.g003
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Fig 4. Partial deletion of the EcN HVR leads to loss of EcN probiotic effects. (a) Schematic display of the deleted parts in the EcNΔ(fliC)HVR
mutant. The orange line depicts the parts of the EcN HVR that were deleted. (b + c) SPF C57BL/6 WT mice aged 6 to 8 weeks were administered
3.5% DSS in drinking water at day 0. Mice were additionally treated with 1010 viable bacteria of EcN or the EcNΔ(fliC)HVR mutant resuspended in
100 mL DSS-containing drinking water. (b) Change in body weight relative to start of DSS administration at day 0. (c) HCS at day 7. Statistical
analysis was performed using Student t test. Error bars represent SD. White dots in column bars represent each biological replicate. (d) Heat map of
cytokine concentrations in serum from DSS-treated mice. Each column represents a different individual. (e) Detailed analysis of cytokine
concentrations from serum depicted in (d). Asterisks indicate statistical significance. All shown cytokines provide the strongest differences between
DSS-treated and DSS + EcNΔfliC(HVR)-treated as well as between DSS + EcN and DSS + EcNΔfliC(HVR)-treated groups. See S1 Table for detailed
statistical analysis using Kruskal–Wallis test with multiple comparisons. p-values< 0.05 are considered to represent statistical significance. (b + c
+ e) The data underlying this figure can be found in S1 Data. CTD, C-terminal domain; DSS, dextran sodium sulphate; EcN, E. coli Nissle 1917; fliC,
flagellin; GM-CSF, granulocyte-macrophage colony-stimulating factor; HCS, histological colitis score; HVR, hypervariable region; IFN, interferon;
IL, interleukin; MCP, monocyte chemoattractant protein; MG1655, E. coli K12 MG1655; MPK, E. coli mpk; NTD, N-terminal domain; ns, not
significant; SPF, specific-pathogen–free; TNF, tumor necrosis factor; WT, wild type.
https://doi.org/10.1371/journal.pbio.3000334.g004
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EcN-flagellin–induced protective effects are mediated by host
TLR5+CD11c+ cells in the colonic LP
So far, we have demonstrated that symbiotic EcN mediated at least a remarkable part of its
symbiotic properties through its flagellin HVR. This effect was dependent on TLR5 expression
in the host. Therefore, we wanted to further elucidate which TLR5-expressing host cell popula-
tion was pivotal for the mediation of the EcN-flagellin–induced effects. The crucial contribu-
tion of TLR5 expression on intestinal epithelial cells (IECs) for maintenance of intestinal
homeostasis has already been reported [37]. Colonic IECs do not only express TLR5 on their
basolateral side [54]. A recent publication demonstrated that colonic IECs also express TLR5
on the luminal side, thus secreting antimicrobial peptides and cytokines in response to flagellin
recognition [55]. However, TLR5-expressing intestinal LP dendritic cells (DCs) also contribute
to flagellin-mediated immune responses [37,56]. Therefore, we were interested in which intes-
tinal cell population mediated the observed symbiotic flagellin-induced inflammation-silenc-
ing properties. Since IECs belong to the group of stromal cells and antigen-presenting cells
such as DCs are derived from hematopoietic stem cells, one can investigate the distinct influ-
ence of these two differentially originated cell types by using bone-marrow–chimeric mice
(BMCM) (Fig 5A). Therefore, we generated different groups of BMCM: (1) WT BL/6 recipient
mice transplanted with bone marrow from Tlr5−/− donor mice (Tlr5−/−!WT), (2) Tlr5−/−
recipient mice transplanted with bone marrow from WT BL/6 donor mice (WT! Tlr5−/−),
and (3) as controls, WT BL/6 recipient mice transplanted with bone marrow from WT BL/6
donor mice (WT!WT). All these animals were SPF-housed and treated with DSS and EcN,
DSS and EcNΔfliC, or DSS only. As demonstrated in Fig 5B, WT! Tlr5−/− mice that were
administered EcN provided low HCS, indicating low colonic inflammation, while the protec-
tive effect of EcN was completely abolished using Tlr5−/−!WT mice (Fig 5B). As seen in WT
BL/6 mice (Fig 1), both groups of BMCM developed severe colitis symptoms when adminis-
tered DSS and the EcNΔfliC deletion mutant. Therefore, we concluded that the protective
effect of EcN flagellin is mainly mediated by cells of hematopoietic origin. CD11c+ cells such
as DCs are one major cell type from the hematopoietic cell lineage mediating microbiota-
derived anti-inflammatory processes in the intestine [41,57]. Therefore, we had a closer look at
CD11c+ cells in the colonic LP (cLP) and their relevance for EcN-mediated symbiotic effects
during DSS-induced colitis.
We generated BMCM restricting TLR5 deficiency largely to CD11c+ cells with a substantial
amount of other hematopoietic cells still expressing TLR5 (Tlr5−/− + ΔCD11c!WT). By
using Tlr5−/− and ΔCD11c donor mice for bone marrow transplantation, we ensured that at
least half of hematopoietic cells other than CD11c+ cells do express TLR5. Generation of these
BMCM was strictly validated (S8 Fig). As demonstrated in Fig 5C, this group provided signifi-
cantly higher inflammation when treated with DSS and EcN compared to WT!WT control
animals that were treated equally. This finding strongly supports the idea that TLR5+CD11c+
cells in the cLP are the main mediators of the symbiotic effects caused by EcN flagellin.
Administration of symbiotic recombinant flagellin prevents intestinal
inflammation
According to our results, we proposed flagellin from a symbiotic E. coli strain to be a suitable
agent in order to prevent pathological intestinal inflammation that was supposed to be rooted
in its increased TLR5 activation capacity. To finally provide evidence for this hypothesis, we
aimed to administer recombinant flagellin from symbiotic and nonsymbiotic E. coli strains to
DSS-treated WT mice. Therefore, we used recombinant flagellin from symbiotic EcN (rfliC
(EcN)) and from nonsymbiotic MG1655 (rfliC(K12)). While rfliC(K12) was commercially
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available, rfliC(EcN) was generated and quality-checked as described in the supplementary
material (S9 and S10 Figs). First, we checked for their ability to induce TLR5 receptor activa-
tion. As seen in Fig 6A, both recombinant flagellins induced IL-8 secretion in mTLR5-HEK293
cells in a concentration-dependent manner. However, rfliC(EcN) induced higher IL-8 secre-
tion compared to rfliC(K12) at a medium-range concentration of 100 ng mL−1, thus indicating
stronger TLR5 receptor activation. Next, we aimed to test the inflammation-preventing prop-
erties of both recombinant flagellins during DSS-induced colitis in mice. Therefore, we used
Fig 5. EcN-flagellin–induced protective effects are mediated by host TLR5+CD11c+ cells in the cLP. (a) Schematic depiction of the generation of
BMCM as described in the experimental procedures. Red dots represent the typical sites of TLR5 expression in the mouse intestine. (b) Different SPF
BMCM were administered 3.5% DSS in drinking water at day 0. Mice were additionally treated with 1010 viable bacteria of EcN or the EcNΔ(fliC)
HVR mutant resuspended in 100 mL DSS-containing drinking water. See text for further information on the nomenclature of distinct BMCM
groups. Indicated p-values refer to the comparison of the respective data set with the WT! Tlr5−/− + DSS + EcN group. Upper panel: HCS at day 7.
Lower panel: HE-stained colonic sections at day 7 after start of DSS administration. (d) Irradiated WT recipient mice were transplanted with bone
marrow from Tlr5−/− and ΔCD11c donor mice in a 1:1 ratio. Mice were administered 3.5% DSS in drinking water at day 0. Mice were additionally
treated with 1010 viable bacteria of EcN resuspended in 100 mL DSS-containing drinking water and compared to control groups. See text for further
information on the BMCM groups nomenclature. Middle panel: HCS at day 7. Right panel: HE-stained colonic sections at day 7 after start of DSS
administration. Statistics: (b) One-way ANOVA with Tukey multiple comparison test, (c) Mann–Whitney test, (d) Kruskal–Wallis test with multiple
comparisons, p-values< 0.05 are considered to represent statistical significance. (b + c) The data underlying this figure can be found in S1 Data.
BMCM, bone-marrow–chimeric mice; cLP, colonic LP; DSS, dextran sodium sulphate; EcN, E. coli Nissle 1917; fliC, flagellin; HCS, histological colitis
score; HE, hematoxylin–eosin; HVR, hypervariable region; LP, lamina propria; SPF, specific-pathogen–free; TLR, Toll-like receptor; WT, wild type.
https://doi.org/10.1371/journal.pbio.3000334.g005
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WT SPF C57BL/6 mice and started daily intragastral gavage of 2 μg recombinant flagellin 3
days prior to start of DSS administration. DSS was administered as 3.5% solution in drinking
water, and flagellin administration was continued daily until the end of the experiment, 7 days
after initial DSS exposure (Fig 6B). The non-flagellin–administered DSS-only–treated control
group was gavaged daily with 100 μL sterile PBS, the solvent flagellin was reconstituted in. As
demonstrated in Fig 6C, administration of rfliC(EcN) resulted in significantly lower tissue
damage in the colon compared to rfliC(K12)-treated and DSS-only–treated mice, therefore
indicating prevention of intestinal inflammation. Lower HCSs in rfliC(EcN)-treated mice
were associated with decreased concentrations of various proinflammatory cytokines in the
blood serum. However, we detected increased serum levels of IL-22 in rfliC(EcN)-treated mice
compared to both other groups (Fig 6D). Since IL-22 contributes to maintenance of intestinal
immune homeostasis by strengthening the intestinal epithelial barrier, we assumed that EcN-
flagellin–induced stronger TLR5-activation was associated with increased IL-22 expression.
The main sources of intestinal IL-22 are reported to be innate lymphoid cells (ILC3s) and
CD4+ T cells, which secrete IL-22 in response to IL-23 [58,59]. Since CD11c is expressed on
various different cell types in the mouse intestine, we further focused on intestinal DCs. Intes-
tinal DCs (intDCs) were defined as being Ly6G/Ly6Cneg, CD45R/B220neg, CD64neg, CD45pos,
and CD11cpos (Fig 6E). Focusing on intDCs in the cLP, however, did not reveal any differences
in IL-23 expression between all compared groups (Fig 6F). This prompted us to check whether
intDCs themselves might be the source of IL-22. In fact, we detected significantly increased
proportions of IL-22+ cells in rfliC(EcN)-treated mice compared to both other groups (Fig 6F),
which correlated with a lower HCS (Fig 6C). Therefore, we assumed that enhanced IL-22
expression by these cells contributed to symbiotic-flagellin–mediated intestinal immune
homeostasis maintenance in DSS-induced colitis.
Discussion
E. coli represents one of the most intensely studied intestinal commensals. Colonization of the
human gut with E. coli starts early after birth even before colonization with anaerobes, which
usually make up the largest part of the human intestinal microbiota [60]. However, distinct
commensal E. coli strains can provide completely different immunogenic properties in a cer-
tain host’s intestine. While pathobiotic commensal E. coli strains may mediate pathophysiolog-
ical immunological processes in a predisposed host, symbiotic commensal E. coli strains may
exhibit even strong probiotic features. Symbionts with beneficial features are widely used to
restore gut homeostasis in human patients and animal models [61]. One of the most promi-
nent and therefore most extensively studied symbiotic E. coli strains is EcN. However, its
symbiotic properties have not yet been linked to a certain molecular or structural feature.
Fig 6. Recombinant FliC protects against DSS-induced colitis. (a) mTLR5-HEK293 cells were stimulated with rfliC(K12) or rfliC(EcN) for 24 h. Resulting IL-8
secretion into cell supernatant as a result of TLR5 receptor activation was detected by ELISA. (b) Experimental setup: SPF C57BL/6 WT mice aged 6 to 8 weeks were
administered 2 μg recombinant flagellin daily via intragastral gavage. 3 days after start of flagellin administration, 3.5% DSS was added to the drinking water. Progress
of DSS-induced colitis was monitored for additional 7 days. (c) HCS and representative HE-stained colonic sections at day 7. Statistical analysis was performed using
the Kruskal–Wallis test. Error bars represent SD. White dots in column bars represent each biological replicate. (d) Heat map of cytokine concentrations in serum
from DSS-treated mice as shown in (b). Each column represents a different individual. Right panel: IL-22 concentration in blood serum. Statistical analysis was
performed using one-way ANOVA. Error bars represent SD. White dots in column bars represent each biological replicate. (e) Gating strategy to define the
population of intDCs from the cLP. Lin = Ly6G/C, CD45R, CD64. (f + g) Proportion of IL-23+ (f) or IL-22+ (g) intDCs from the experiment shown in (b).
Representative histograms or contour blots are shown. Statistical analysis was performed using one-way ANOVA. Error bars represent SD. White dots in column bars
represent each biological replicate. p-values< 0.05 are considered to represent statistical significance. (a + c + d + f + g) The data underlying this figure can be found
in S1 Data. cLP, colonic LP; DC, dendritic cell; DSS, dextran sodium sulphate; EcN, E. coli Nissle 1917; fliC, flagellin; FSC, forward scatter; HCS, histological colitis
score; HE, hematoxylin–eosin; IL, interleukin; intDC, intestinal DC; LP, lamina propria; MG1655, E. coli K12 MG1655; mTLR5-HEK293 cell, mouse-TLR5–
overexpressing human embryonic kidney 293 cell; ns, not significant; rfliC(EcN), recombinant flagellin from EcN; rfliC(K12), recombinant flagellin from MG1655;
SPF, specific-pathogen–free; TLR, Toll-like receptor.
https://doi.org/10.1371/journal.pbio.3000334.g006
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Interestingly, studies using outer-membrane vesicles from EcN have revealed that these vesi-
cles are able to mimic the properties of viable EcN, thus indicating that any surface-associated
component might be crucial for the mediation of its symbiotic capacities [62]. An important
surface-associated molecule of EcN is flagellin, the constitutive protein of the bacterial flagel-
lum. Most clinically relevant E. coli strains express flagella on the cell surface [63], thus render-
ing bacteria motile and facilitating bacterial attachment to the intestinal mucus [46]. Since
flagellin represents one of the most important antigens in IBD patients [33], we assumed that
the definite flagellin structure might contribute to the symbiotic properties of certain E. coli
strains and is therefore involved in modulation of IBD pathogenesis.
With this study, we found the HVR of flagellin to strongly influence the immunogenic
properties of the tested commensal E. coli strains. Unexpectedly, we observed that symbiotic
EcN harbors a substantially longer HVR, comprised of various small inserts, compared to non-
symbiotic commensal E. coli strains. Previous work on structure-function relationship for fla-
gellin–TLR5 interactions have focused on the so-called N- and C-terminal D0 and D1
domains of flagellin that make up the protein’s constant region and that are highly conserved
among all flagellins across different bacterial phyla [50,51]. This constant region was also char-
acterized as being crucial for interaction with TLR5 and therefore for TLR5-mediated intracel-
lular signaling in host cells [29,30]. Given the high similarity of EcN, MPK, and MG1655 in
this region, it was therefore surprising to detect a significant difference between symbiotic and
nonsymbiotic strains in the ability to induce TLR5-mediated signaling. Flagellin of EcN, har-
boring the substantially longer HVR, induced significantly stronger TLR5-mediated signaling
compared to the tested nonsymbiotic E. coli strains. This indicated an unexpected contribution
of the HVR D2 and D3 domains to TLR5 activation.
Andersen-Niessen and colleagues reported that flagellin’s N-terminal D1 domain predomi-
nantly determined its TLR5-stimulatory activity. However, this required additional contribu-
tion from the HVR D2/D3 and the CD1 domain [64]. This might indicate that HVR domains
generally have a stronger impact on TLR5 activation than could have been gleaned from only
the crystal structure of TLR5 and flagellin [30]. This structure shows zebrafish TLR5 in com-
plex with Salmonella FliC, out of which 100 amino acids in the HVR of Salmonella are not
structurally resolved. This indicates that parts of the HVR might be highly flexible and/or do
not stably interact with TLR5, at least with zebrafish TLR5. The situation may be different for
the murine TLR5 that was investigated here.
Since the D3 domain of Salmonella flagellin contributes to the stability of flagellin mono-
mers [65], which is a prerequisite for TLR5 receptor activation, it might be possible that the
HVR of symbiotic E. coli strains also positively regulates monomer stability, whereas mucus
attachment, another function of flagellin, has been shown to be independent of the D3 region
[46] and thus probably not relevant here. Although the precise molecular mechanism by
which the HVR modulates TLR5 signaling thus remains to be established, our functional data
warrant a more thorough exploration of this region, both functionally and structurally.
While extracellular flagellin is sensed by TLR5, leading to MyD88-dependent NFκB activa-
tion, flagellin present in the cytosol results in activation of the NLR Family CARD Domain
Containing 4 (NLRC4) inflammasome [32]. NLRC4 activation leads to IL-1β and IL-18 secre-
tion, and the NLRC4 inflammasome helps to discriminate harmful pathogens from beneficial
commensals [66]. However, we assume that potential NLRC4-inflammasome–mediated effects
play a neglectable role concerning the discrimination of symbiotic from nonsymbiotic E. coli
strains because of two reasons: first, flagellin recognition by the NLRC4 inflammasome com-
ponent NLR family, apoptosis inhibitory protein 5 (NAIP5) is crucially mediated by 35 amino
acids within the flagellin CD0 domain [67], which is identical in all tested strains. Secondly, we
demonstrated that flagellin-HVR–mediated symbiotic effects were completely abolished in
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TLR5-deficient mice and FEPs were sufficient to mediate symbiotic properties, therefore indi-
cating that TLR5-dependent sensing of extracellular flagellin is far more important than a
potential intracellular NLRC4 inflammasome activation in our system.
But how can it be explained that a stronger intestinal TLR5 signaling, induced by a symbi-
otic commensal, correlates with beneficial effects during DSS-induced colitis accompanied by
lower systemic cytokine levels? Systemic loss of TLR5 signaling was shown to entail an over-
growth of flagellated members of the intestinal microbiota, promoting inflammatory condi-
tions [48,56]. Furthermore, certain SNPs in the human TLR5 gene are associated with higher
incidence of IBDs [68,69]. Therefore, TLR5 expression and signaling seem to be necessary to
maintain a balanced homeostatic microbiota composition and intestinal immune homeostasis.
This effect has been mostly traced back to TLR5 signaling in IECs, which is suspected to lead
to immune cell recruitment, which mediates clearance from bacteria breaching the mucus bar-
rier [37]. However, using BMCM, we have identified intestinal LP CD11c+ cells as crucially
contributing to the EcN-flagellin–mediated symbiotic effects. This observation is in line with
findings that TLR5 on hematopoietic cells is involved in flagellin sensing [70] and flagellin-
dependent activation of Th17 cells [56]. Furthermore, SNP-mediated differences in TLR5 sig-
naling were observed to affect immune cells rather than epithelial cells.
Besides IECs, CD11c+ cells such as DCs are the most important TLR5-expressing cells at
intestinal mucosal interfaces [71]. We demonstrated that symbiotic-flagellin–mediated benefi-
cial effects on the progress of DSS-induced colitis was associated with increased serum levels
of IL-22 as well as with a higher proportion of IL-22+ intDCs. In general, IL-22 contributes to
restoration of intestinal homeostasis, promotes regeneration of damaged intestinal epithelium
[72], modulates epithelial cell fucosylation [73], and induces the secretion of antimicrobial
peptides [74,75] and mucins [76]. Therefore, it represents a pivotal cytokine in modulation of
intestinal tissue responses during inflammatory processes. In intestinal tissue, IL-22 is mainly
produced by ILC3 cells [59], CD4+ T cells [77], and, to a lesser extent, CD8+ T cells, T-cell
receptor (TCR)γδ T cells, neutrophils, and natural killer (NK) cells [78,79]. ILC3 and CD4+ T
cells secrete IL-22 mainly in response to IL-23 [58,59,77]. In this connection, intDCs play a
decisive role in shaping the LP cytokine milieu in response to intestinal microbiota sensing.
However, even intDCs themselves emerged as sources of gastrointestinal IL-22 [75,80,81]
which is in line with our observations. Therefore, we hypothesize that symbiotic flagellin, bear-
ing a longer HVR, leads to stronger TLR5 signaling in intDCs, resulting in enhanced IL-22
expression and thus contributing to maintenance of the intestinal barrier. Since disruption of
the intestinal barrier provides a characteristic of DSS-induced colitis, IL-22 was demonstrated
to play a pivotal role in counteracting inflammatory processes in this disease model [81–83].
However, and to date, we cannot completely exclude a merely indirect contribution of intDCs
by modulating IL-22 secretion through ILC3 cells or T cells. This indirect influence might
occur via secretion of ILC3- and T-cell–activating cytokines by CD11c+ cells other than
intDCs. Nevertheless, our results indicate intDCs to be, at least partially, direct sources of IL-
22 in response to different flagellins, which, in turn, might account for the observed distinct
DSS-induced colitis phenotypes mediated by administration of different flagellins. Thus, para-
doxically, a symbiotic-flagellin–mediated stronger TLR5 signaling based on its flagellin HVR
structure might contribute to the observed lower inflammatory status of symbiotic-flagellin–
administered DSS-treated mice.
Interestingly, flagellin-dependent TLR5 signaling was also demonstrated to be involved in
the mediation of symbiotic properties of another gut commensal, Roseburia hominis [84], and
may thus be a more common phenomenon than previously thought. However, the role of cer-
tain cell subtypes within the intestinal tissue mediating the decisive beneficial effects in
response to flagellin still remains to be further elucidated. While we propose intDCs from the
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cLP to be the most important cell type to promote inflammation-preventing events during
DSS-induced colitis, Uematsu and colleagues demonstrated CD11c+ cells from Peyer’s Patches
(PPs) in the small intestine to be responsible for flagellin-induced IL-10 secretion, which
might, in turn, contribute to homeostasis, while LP CD11c+ cells instead promote secretion of
proinflammatory cytokines [85]. Therefore, both studies accentuate the contribution of intesti-
nal CD11c+ cells on host immune homeostasis by sensing flagellin from luminal microbes,
even though different CD11c+ cell populations emerged as crucial. Since our study focused on
DSS-induced colitis, we did not further investigate cells from noncolonic gastrointestinal tis-
sues. Uematsu and colleagues, on the other hand, did not investigate homeostasis-promoting
mechanisms other than IL-10 secretion. Thus, both results are not necessarily contradictory.
Nevertheless, more studies have to be conducted to uncover the role of CD11c+ cells all across
the gastrointestinal tract in terms of flagellin-mediated immunological reactions.
In addition to local intestinal effects, the E. coli-flagellin-HVR–mediated impact on the
progress of DSS-induced colitis in mice was accompanied by regulation of systemic expression
of various pro- and anti-inflammatory cytokines. The most important pathology-promoting
cytokines in IBD patients are IL-1β, IL-6, TNFα, IFNγ, and IL-17 [86]. We demonstrated that
the EcN-administration–associated decrease of IL-1β, IL-17, IL-6, and TNFα serum levels in
DSS-treated mice is abolished when an EcN deletion mutant is used that lacks large parts of its
flagellin HVR. Therefore, the E. coli flagellin HVR seems to be involved in the regulation of
systemic expression of such IBD-promoting cytokines. However, we think that this is instead a
secondary effect, probably rooted in IL-22–mediated increased epithelial barrier integrity, thus
preventing inflammation-driving translocation of luminal content.
Interestingly, Rakoff-Nahoum and colleagues demonstrated in 2004 that proper TLR2- and
TLR4-signaling protects from DSS-induced mortality in microbiota-depleted mice, which is
assumed to be necessary for ligand-dependent steady-state induction of protective factors [87].
Our data indicate that intestinal TLR5 signaling might also contribute to these fundamental
homeostasis-preserving mechanisms.
Taken together, we propose the flagellin HVR structure may be a distinguishing marker for
the classification of E. coli strains as either nonsymbiotic or symbiotic. Furthermore, we dem-
onstrated that flagellin-mediated symbiotic effects were originated in the structure of the fla-
gellin HVR, which, in turn, influences TLR5-mediated intracellular signaling in intestinal
CD11c+ cells, accompanied by regulation of IBD-promoting cytokines. These insights might
therefore offer new possibilities for drug development involving existing or custom-designed
flagellin structures, especially for intestinal inflammatory disorders such as IBD.
Materials and methods
Ethics statement
In this study, we use WT C57BL/6 and TLR5-deficient animals as well as BMCM as described
in the manuscript. This study was carried out in accordance with the principles of the Basel
Declaration. Protocols and experiments involving mice were reviewed and approved by the
responsible Institutional Review Committee and the local authorities (permit numbers: H3/18,
H9/11, H5/10). All mice used in the experiments were killed by CO2 fumigation, as demanded
by the responsible authorities. Mice were weighed daily, and a general checkup of the animals’
constitution was performed daily. A weight loss of more than 20% compared to the start of the
experiment is an indicator for unacceptable suffering, leading to immediate euthanization of
the respective animal. Additionally, the general constitution of the mouse was evaluated
according to a score sheet that was approved by the responsible authorities. Exceeding a cer-
tain score requires immediate euthanization of the mouse. However, no mouse used for the
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experiments in the submitted manuscript was required to be euthanized before the projected
end of each experiment.
Mice
C57BL/6N (WT) and Tlr5−/− mice were bred and raised under SPF conditions in the animal
facility at the University of Tu¨bingen, Germany and did not provide any signs of spontaneous
colitis. CD11cCre/R-DTA (ΔCD11c) [88] mice were bred under SPF conditions at the animal
facility of the University of Erlangen. All animal experiments were reviewed and approved by
the responsible authorities.
Generation of BMCM
Mice were irradiated in a gamma cell (GammaCell 1000 Elite; Nordion International, Ottawa,
ON, Canada) with 900 cGy (female) or 950 cGy (male). Six hours after irradiation, mice were
injected intravenously with freshly isolated bone marrow cells (1 × 107 cells/100 μL PBS) from
donor mice. Bone marrow cells were isolated as described previously [41] with minor modifi-
cations. Mice were administered Cotrim E (26 mg/100 mL sterile drinking water, purchased
from Ratiopharm, Ulm, Germany) for the first two weeks after irradiation. Six weeks after irra-
diation, blood was analyzed for successful reconstitution of the transplanted bone marrow by
flow cytometry. BMCM were used for induction of DSS-induced colitis as described below.
Bacteria
Mice were administered EcN, the isogenic mutant EcNΔfliC [46], the nonsymbiotic MG1655
[89], and pathobiotic MPK [41,42,44]. Furthermore, an MG1655ΔfliC mutant was comple-
mented with the fliC gene from EcN (MG1655ΔfliC::fliC(EcN)) and an EcNΔfliC mutant was
complemented with the fliC gene from MPK (EcNΔfliC::fliC(MPK)), and both were adminis-
tered to mice. The EcNΔfliC(HVR) mutant lacks large parts of the HVR within the fliC gene.
All strains were grown at 37˚C in LB broth under aerobic conditions.
Generation of FEPs
Bacteria were grown in LB broth as described above. Bacteria were centrifuged at 4,000 rpm,
and the cell pellet was resuspended in proteinase inhibitor cocktail (Roche, Basel, Switzerland)
and shaken vigorously for 10 min. The suspension was centrifuged for 15 min (4,000 rpm,
4˚C), and the supernatant was used as an FEP.
Administration of live bacteria, FEPs, or recombinant flagellin to mice
We observed the progress of DSS-induced colitis in mice in response to treatment with viable
bacteria, FEPs, or recombinant flagellin. Treatment with viable bacteria started 3 days prior to
start of DSS administration by one-time intragastral gavage of a total of 108 bacteria. Simulta-
neously, autoclaved drinking water was supplemented with viable bacteria at a final concentra-
tion of 108 mL−1. 3 days after initial intragastral gavage, DSS was added to drinking water
suspensions at a final concentration of 3.5% (w/v). Drinking water containing bacteria and
DSS were renewed every 2 days until the end of the experiment. Colonization with viable bac-
teria was assessed by determination of CFUs, as described in the supplementary material.
Administration of FEPs to DSS-treated mice was comparable: FEPs obtained from 107 or 1010
bacteria were resuspended in 100 μL autoclaved drinking water and administered once by
intragastral gavage 3 days prior to the start of DSS administration. Subsequent treatment with
FEPs for the next 10 days was performed by generating drinking water suspensions containing
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FEPs from 107 or 1010 in 100 mL drinking water. DSS was added to the drinking water suspen-
sion 3 days after initial FEP administration, and suspensions were renewed every 2 days.
Recombinant flagellin was also started to be administered 3 d before start of DSS treatment. A
total of 2 μg recombinant flagellin was administered daily by intragastral gavage for a total of
10 d. DSS treatment started 3 d after initial flagellin administration, and DSS solutions were
renewed every 2 d.
Generation of pure recombinant EcN flagellin preparations
Chemocompetent NiCo BL21 (D3) E. coli were transformed by heatshock with a pET19-b
expression vector harboring the His-tagged sequence for EcN flagellin (FliC(EcN)). After
recovery time, transformed bacteria were inoculated into ampicillin-containing LB medium
and incubated at 37˚C O/N. An aliquot of the O/N culture was grown until OD = 0.6. 200 μM.
IPTG was added to induce lac-operon controlled protein expression of rfliC(EcN). Bacterial
culture was grown O/N at 18˚C and 90 rpm, and cells were harvested by centrifugation at
17,000 rpm and 4˚C. The pellet was lysed for 15 min on ice using protease-inhibitor–and ben-
zonase-containing lysis buffer (300 mM NaCl, 50 mM Tris-HCl [pH 8.0], 5 mM imidazole) at
a ratio of 10 mL buffer per gram pellet followed by sonification on a Branson 250 sonifier
(Branson Ultrasonics, Danbury, CT, USA). Lysates were centrifuged at 35,000 rpm for 45 min
at 4˚C. The 1 mL HisTrap Column (GE Healthcare Life Sciences, Marlborough, MA, USA)
was equilibrated with equilibration buffer (300 mM NaCl, 50 mM Tris-HCl [pH 8.0]), and bac-
terial lysate was loaded on the column afterwards. Protein binding to the HisTrap Column was
performed O/N. Next, columns were washed with various concentrations of elution buffer
(300 mM NaCl, 50 mM Tris-HCl [pH 8.0], 500 mM imidazole), ranging from 3% to 100%. At
20% elution buffer, His-tagged rfliC(EcN) started to be eluted, and elute fractions were col-
lected. Fractions were analyzed via SDS-PAGE and α-fliC western blotting as demonstrated in
the supplementary material (S9 and S10 Figs).
Isolation of LP cells and staining for flow cytometry
LP cells from the colon were isolated as published previously [41,57] with minor modifica-
tions. Cells were stained for viability using ViabilityStain (eBioscience, Thermo Fisher Scien-
tific, Waltham, MA, USA) according to the manufacturer’s instruction. 2 × 106 cells were
incubated in DMEM (Gibco, Gaithersburg, MD, USA) supplemented with 10% FCS, 1%
HEPES, 1% nonessential amino acids, 1% sodium pyruvate, 0.5% penicillin/streptomycin,
0.5% β-mercaptoethanol, and 2 μL leukocyte activation cocktail (BD Biosciences, San Jose,
CA, USA) for 4 h at 37˚C. Cells were washed and fixed with Cytofix/Cytoperm (BD Biosci-
ences). Cells were washed in PBS/FCS containing 0.1% saponin and treated with Cytofix/Cyto-
perm (BD Biosciences) for 10 min at RT. Antibodies were diluted by factor 100 in PBS/FCS
+ 0.1% saponin and incubated with cells for 30 min at 4˚C. Cells were washed twice, and flow
cytometrical detection was performed subsequently.
Antibodies, chemicals, and reagents
For flow cytometry, the following antibodies were used: α-mouse IL-22 (1H8PWSR;
eBioscience), α-mouse IL-23p19 (N71-1183; BD Biosciences), α-mouse CD11c (HL3; BD Bio-
sciences), α-mouse CD64 (X54-5/7.1; BD Biosciences), α-mouse CD45 (30-F11; BD Biosci-
ences), α-mouse CD45R (RA3-6B2; BD Biosciences), and α-mouse Ly6G/C (GR-1/RB-68C5;
BD Biosciences). Recombinant flagellin from MG1655 was obtained from MyBioSource
(#MBS1265520; San Diego, CA, USA).
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DSS-induced colitis
Mice were administered live bacteria, recombinant flagellin, or FEP 3 days prior to challenging
with 3.5% (w/v) DSS in drinking water and during the whole course of the experiment as
described above. Body weight was determined on day 0 (start of DSS administration) as well as
on days 3 to 7.
Statistical analysis
For comparisons of two groups, a parametric Student t test was used for normally distributed
values and nonparametric Mann–Whitney test elsewhere. For multiple comparison of more
than two groups, one-way ANOVA was used for normally distributed values, and nonpara-
metric Kruskal–Wallis test was used elsewhere. p-values are indicated in the figures. p-
values< 0.05 were considered to be significant.
See Supplementary material S1 Text for additional information on experimental
procedures.
Supporting information
S1 Fig. Determination of E. coli CFUs in the feces of DSS-treated mice. SPF C57BL/6 WT
mice (a) and Tlr5−/− mice (b) aged 6 to 8 weeks were administered 3.5% DSS in drinking water
at day 0. Mice were additionally treated with EcN (DSS + EcN), MG1655 (DSS + MG1655),
MPK (DSS + MPK), or the EcN ΔfliC deletion mutant (EcNΔfliC) resuspended in DSS-con-
taining drinking water at 108 bacteria mL−1. At day 7 after start of DSS administration, feces
were plated on Enterobacteriaceae-specific agar in serial dilutions and CFUs were determined
by counting dark red colonies specific for E. coli strains. (a + b) The data underlying this figure
can be found in S1 Data. CFU, colony-forming unit; DSS, dextran sodium sulphate; EcN, E.
coli Nissle 1917; fliC, flagellin; MG1655, E. coli K12 MG1655; MPK, E. coli mpk; SPF, specific-
pathogen–free; TLR, Toll-like receptor; WT, wild type.
(PNG)
S2 Fig. EcN, MPK, and MG1655 express functional flagella. Right column: overnight cul-
tures of MPK, EcN, and MG1655. Overnight bacterial culture was seeded in the middle of a
swarming culture medium and incubated for 24 h. The inoculation spot is indicated by a red
circle, and the borders of the swarming area are highlighted with a white scattered line. Left
column: electron microscopy pictures (negative staining) of EcN (upper panel), MPK (middle
panel), and MG1655 (lower panel) highlighting the respective flagellum (red arrows). MPK
lost its flagella during the staining procedure and could be detected as the shed structure. The
insert in the respective picture (left column, middle panel) shows an MPK bacterium. EcN, E.
coli Nissle 1917; MG1655, E. coli K12 MG1655; MPK, E. coli mpk.
(PNG)
S3 Fig. EcNΔfliC does not express a functional flagellum. Right: overnight bacterial culture
of EcNΔfliC was seeded in the middle of a swarming culture medium and incubated for 24 h.
The inoculation spot is indicated by a red circle, and the borders of the swarming area are
highlighted with a white scattered line. Left column: electron microscopy pictures (negative
staining) of EcNΔfliC (highlighting the absence of flagella). EcN, E. coli Nissle 1917; fliC, flagel-
lin.
(PNG)
S4 Fig. Characterization of FEPs. EcN, MPK, and MG1655 were grown to OD100, and FEPs
were generated as described in the main manuscript. (a) Silver staining of 10 μL FEP on an
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8%–15% gradient SDS gel. (b) LAL test to determine endotoxin levels in FEPs. (c) Determina-
tion of overall protein concentration in FEPs using a bicinchoninic acid assisted assay. (d)
Western blot of FliC of 10 μL FEPs using anti-flagellin antibody (ab93713; Abcam, Cambridge,
UK). (e) Quantification of FliC concentrations in FEPs. Band intensities of FliC bands in west-
ern blots depicted in (d) were quantified. A standard curve of recombinant EcN FliC was gen-
erated and visualized with the same antibodies on the same blots. FliC concentrations were
computed using the determined FliC band intensities in relation to a linear regression of the
band intensities of FliC standard curve. (b + c + e) The data underlying this figure can be
found in S1 Data. EcN, E. coli Nissle 1917; FEP, flagella-enriched preparation; fliC, flagellin;
LAL, limulus amebocyte lysate; MG1655, E. coli K12 MG1655; MPK, E. coli mpk; OD, optical
density.
(PNG)
S5 Fig. Generation of fliC exchange mutant strains. Chromosomal exchange of fliC alleles
was done by allelic exchange as described previously [90]. Upper panel: suicide plasmids were
constructed by Gibson assembly according to standard protocols [91]. Lower panel: primers
and plasmids for allelic exchange as well as resulting strains. fliC, flagellin.
(PNG)
S6 Fig. MG1655ΔfliC::fliC(EcN) and EcNΔfliC::fliC(MPK) express a functional flagella.
Right column: overnight bacterial culture of MG1655ΔfliC::fliC(EcN) and EcNΔfliC::fliC
(MPK) exchange mutants were seeded in the middle of a swarming culture medium and incu-
bated for 24 h. The inoculation spot is indicated by a red circle, and the borders of the swarm-
ing area are highlighted with a white scattered line. Left column: electron microscopy pictures
of MG1655ΔfliC::fliC(EcN) and EcNΔfliC::fliC(MPK) highlighting the respective flagella (red
arrow). EcN, E. coli Nissle 1917; fliC, flagellin; MG1655, E. coli K12 MG1655; MPK, E. coli
mpk.
(PNG)
S7 Fig. EcNΔflic(HVR) expresses a shorter flagella compared to WT EcN. Left panel: EM
pictures of EcNΔfliC(HVR) deletion mutants highlighting the flagella (red arrow). Right panel:
EM-assisted determination of flagella lengths. Each white dot represents one detected flagel-
lum in EM pictures. The data underlying this figure can be found in S1 Data. EcN, E. coli Nis-
sle 1917; EM, electron microscopy; fliC, flagellin; HVR, hypervariable region; WT, wild type.
(PNG)
S8 Fig. Schematic illustration of generation of BMCM. (A) Tlr5−/−!WT mice by irradia-
tion of C57BL/6×WT-CD45.1–expressing mice transplanted with bone marrow of C57BL/
6×Tlr5−/−-CD45.2–expressing mice and (B) WT! Tlr5−/− mice by irradiation of C57BL/
6×Tlr5−/−-CD45.2–expressing mice transplanted with bone marrow of C57BL/
6×WT-CD45.1–expressing mice. (C) Irradiated C57BL/6-CD45.2 mice transplanted with
C57BL/6-CD45.1 bone marrow (WT!WT), (D) Tlr5−/−CD45.2 mice transplanted with
Tlr5−/−-CD45.2 bone marrow (Tlr5−/−! Tlr5−/−). Successful transplantation was monitored
by flow cytometry analysis of blood samples stained with antibodies against CD45.1 and
CD45.2. Figures show means ± SD of 4 to 9 mice per experiment. BMCM, bone-marrow–chi-
meric mice; TLR, Toll-like receptor; WT, wild type.
(PNG)
S9 Fig. Validation of rFliC(EcN) purity. Coomassi-stained 4%–15% gradient gel of all col-
lected eluted fractions after elution from HisTrap columns using elution buffer (300 mM
NaCl, 50 mM Tris-HCl [pH 8.0], 500 mM imidazole) at concentrations from 20% to 100%.
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EcN, E. coli Nissle 1917; fliC, flagellin; rfliC(EcN), recombinant flagellin from EcN.
(PNG)
S10 Fig. Western blot of rFliC(EcN). Western blots against the His-tags of rFliC(EcN) (left
panel) and FliC (right panel) were performed to verify the proper expression of the recombi-
nant protein. Cell lysates before IPTG-assisted induction of protein expression (preinduction),
after IPTG-assisted induction (postinduction), the collected elutes from the HisTrap column
(Elute) (see S9 Fig), and a previously purified MS-controlled rFliC(EcN) as positive control
were loaded on a 4%–15% gradient gel, and western blots were performed as described. EcN,
E. coli Nissle 1917; fliC, flagellin; MS, mass spectrometry; rfliC(EcN), recombinant flagellin
from EcN.
(PNG)
S1 Table. Detailed statistical analysis of the values depicted in Fig 1E as determined by
one-way ANOVA.
(DOCX)
S2 Table. Statistical analysis of cytokine serum levels in DSS-treated mice. p-values were
computed using nonparametric Kruskal–Wallis test. DSS, dextran sodium sulphate.
(DOCX)
S1 Data. Raw data underlying the following figures: Fig 1, Fig 2, Fig 4, Fig 5, Fig 6, S1 Fig,
S4 Fig, S7 Fig.
(XLSX)
S1 Text. Supplementary methods.
(DOCX)
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